TNFRSF11A and rheumatoid arthritis: Future research should focus on unveiling the molecular mechanisms through which RANKL gene polymorphisms influence RA susceptibility and on developing targeted therapies that intervene in the RANK/RANKL/osteoprotegerin pathway.